Adverum Biotechnologies (ADVM)
2.65
+0.00 +0.00%
NASDAQ
Jul 20, 16:59
Delayed 2m
USD
View All Key Stats
ADVM Key Stats
| Income Statement | |
| Revenue (TTM) | 1.652M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.97 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -114.45M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -3.48K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 113.60M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 64.34 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.5641 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -12.08M |
| Return on Equity (TTM) | -50.09% |
View All ADVM News
ADVM News
-
WireHeadlineTime (ET)
-
SA Breaking News07/07 17:37
-
MT Newswires06/20 11:07
-
Globe Newswire06/20 09:00
-
Yahoo06/20 09:00
-
PR Newswire06/01 08:00
-
Globe Newswire05/22 08:30
-
Yahoo05/15 15:10
-
Yahoo05/12 11:57
-
Globe Newswire05/10 17:30
-
SA Breaking News05/09 18:03
View All Events
ADVM Events
| Date | Type | Description |
|---|---|---|
| 03/06/2017 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2016 |
| 11/08/2016 | Earnings | Adverum Biotechnologies Inc Third Quarter Earnings Results in 2016 |
| 08/09/2016 | Earnings | Adverum Biotechnologies Inc Second Quarter Earnings Results in 2016 |
ADVM Fundamentals
Income Statement View Statement
ADVM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ADVM One Page Reports
- One Page Report Download
ADVM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 2.65 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.avalanchebiotech.com
- Investor Relations URL: http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Mar. 06, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
ADVM Comparables
EditADVM Excel Add-In Codes
- Name: =YCI("ADVM","name")
- Description: =YCI("ADVM","description")
- Sector: =YCI("ADVM","sector")
- Industry: =YCI("ADVM","industry")
- Est. Current Fiscal Year End: =YCI("ADVM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ADVM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ADVM Tweets Stocktwits
Advertisement
